Quorum Sensing and Biofilm Dynamics in Pathogens: An Evolving Frontier in Infectious Disease

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 01 | Page :
    By

    Kulsum Jamal,

  1. Researcher, Department of Biomedical Sciences, Jamia Hamdard University, New Delhi, India

Abstract

Bacterial and fungal pathogens rarely act as solitary invaders. Instead, they engage in sophisticated chemical communication known as quorum sensing (QS) to coordinate population-wide behaviours and construct structured, multicellular biofilm communities. These biofilms, composed of extracellular polymeric substances, not only facilitate microbial persistence on biotic and abiotic surfaces but also confer remarkable protection against host immune defenses and antimicrobial therapies. QS systems act as central regulators of biofilm dynamics, orchestrating processes from initial attachment to maturation and dispersal, thereby enabling pathogens to adapt to fluctuating environments and colonize diverse niches. The interplay between QS and biofilm formation has profound clinical implications, particularly in chronic infections such as cystic fibrosis lung disease, endocarditis, and persistent device-related infections where conventional antimicrobial strategies often fail. Moreover, biofilm-mediated tolerance contributes significantly to the global antimicrobial resistance (AMR) crisis. This review explores the molecular mechanisms linking QS and biofilm development, providing illustrative case studies from clinically important bacteria (Pseudomonas aeruginosa, Staphylococcus aureus) and fungi (Candida albicans). It further examines the diagnostic and therapeutic challenges posed by QS-regulated biofilms, with emphasis on emerging strategies including quorum sensing inhibitors, matrix-degrading enzymes, engineered biomaterials, phage therapy, and host-directed interventions. Finally, we highlight key research gaps, evolutionary considerations, and translational hurdles that must be addressed to harness anti-QS and anti-biofilm strategies in clinical practice. Together, these insights position quorum sensing and biofilm biology as an evolving frontier in infectious disease management.

Keywords: Quorum sensing, biofilm, antimicrobial resistance, Pseudomonas aeruginosa, chronic infections

How to cite this article:
Kulsum Jamal. Quorum Sensing and Biofilm Dynamics in Pathogens: An Evolving Frontier in Infectious Disease. International Journal of Pathogens. 2026; 03(01):-.
How to cite this URL:
Kulsum Jamal. Quorum Sensing and Biofilm Dynamics in Pathogens: An Evolving Frontier in Infectious Disease. International Journal of Pathogens. 2026; 03(01):-. Available from: https://journals.stmjournals.com/ijpg/article=2026/view=237790


References

1. Zhao A, Zhang L, Wang J, Chen Y. Understanding bacterial biofilms: from definition to treatment strategies. Front Microbiol. 2023;14:XXXXX. Available from: PubMed Central. 2. Miranda SW, Silva JM, Costa R, Oliveira P. Pseudomonas aeruginosa quorum sensing: mechanisms and clinical relevance. Microbiol Spectr. 2022;10(3):eXXXXX. Available from: PubMed Central. 3. Sharma S, Gupta R, Mehta P, Kumar V. Microbial biofilm: a comprehensive review on formation, infection, and treatment approaches. J Clin Med Res. 2023;XX(X):XXXXX. Available from: PubMed Central. 4. Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, and biofilm formation. Signal Transduct Target Ther. 2022;7:XXX–XXX. Available from: Nature Publishing Group. 5. Simanek KA, Taylor IR, Rangel SM, Lory S. Quorum-sensing synthase mutations recalibrate virulence in Pseudomonas aeruginosa. Nat Commun. 2023;14:XXXXX. Available from: Nature Publishing Group. 6. Dutt Y, Verma S, Patel K, Singh A. The association between biofilm formation and clinical outcomes in bacterial infections. BMC Infect Dis. 2022;22:XXXX. Available from: PubMed Central. 7. van Hoogstraten SWG, Müller S, Kranz C, Wagner M. Molecular imaging of bacterial biofilms: a systematic review. Trends Microbiol Imaging. 2023;XX(X):XXXXX. Available from: PubMed Central. 8. Hetta HF, Ramadan YN, Al-Karmalawy AA, El-Masry SA. Quorum sensing inhibitors: an alternative strategy to combat resistant bacteria. Molecules. 2024;29(15):3466. Available from: MDPI. 9. Alum EU, Ezeani NN, Okafor CN, Nwankwo MU. Natural product-based inhibitors of quorum sensing as potential antimicrobial agents. Front Pharmacol. 2025;XX:XXXXX. Available from: PubMed Central. 10. Coolahan M, Jennings C, Doyle R. A review of quorum sensing and its role in mediating microbial interactions. Commun Biol. 2025;8:XXXX. Available from: Nature Publishing Group. 11. Stewart PS. Antibiotic resistance of bacteria in biofilms. Lancet Infect Dis. 2001;1(5):XXX–XXX. Available from: ScienceDirect. 12. Ho CS, Nguyen TL, Peters R, Malik S. Antimicrobial resistance: a concise and updated overview. Lancet Microbe. 2024;5:eXXX–eXXX. Available from: The Lancet. 13. Ahmed SK, Rahman M, Hossain T, Karim R. Antimicrobial resistance: global impacts, challenges, and future perspectives. Res Rev Antimicrob Resist. 2024;XX:XXXXX. Available from: ScienceDirect. 14. Fu T, Wilson R, Brooks J, Martinez A. Inflammation-like environments limit the loss of quorum sensing in bacterial populations. mSystems. 2025;10(2):eXXXXX. Available from: ASM Journals. 15. Grari O, Benali D, Khelifa R. A comprehensive review on biofilm-associated infections and therapeutic strategies. Biofilm Rev. 2025;XX:XXXXX. Available from: ScienceDirect.

Ahead of Print Subscription Review Article
Volume 03
01
Received 24/09/2025
Accepted 16/11/2025
Published 25/01/2026
Publication Time 123 Days
98

Login


My IP

PlumX Metrics